GlassScriptPhysician profile
Matthew N Silverman
NPI 1003811522
$993.45
in general payments reported to CMS, 2019-2025
17 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.67 · 2020: $48.00 · 2021: $114 · 2022: $113 · 2023: $125 · 2024: $304 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $143.48 | 2024-2025 | Veozah |
| Exeltis, USA INC. | $132.38 | 2022-2024 | Slynd |
| Aspira Women'S Health INC | $104.64 | 2021-2022 | |
| Coopersurgical, INC. | $103.76 | 2024-2025 | Paragard T 380a |
| Daiichi Sankyo INC. | $103.59 | 2020-2021 | |
| Shield Therapeutics INC | $76.83 | 2023-2025 | Accrufer |
| Organon LLC | $51.52 | 2024 | |
| Novo Nordisk INC | $46.06 | 2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $43.96 | 2023-2024 | Gardasil 9, Gardasil |
| Sumitomo Pharma America, INC. | $37.46 | 2023 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $34.92 | 2022 | |
| Lilly USA, LLC | $27.21 | 2019 | |
| Pfizer INC. | $21.86 | 2024 | |
| Abbvie INC. | $20.29 | 2024 | |
| Hologic Sales and Service, LLC | $17.39 | 2024 | Aptima |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $15.64 | 2021 | |
| Allergan, INC. | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Silverman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.